You have 9 free searches left this month | for more free features.

Phase 2 Pilot Trial

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Colorectal Carcinoma (CRC), Endometrial Carcinoma (EC) Trial in Oklahoma City (TPST-1495)

Not yet recruiting
  • Colorectal Carcinoma (CRC)
  • Endometrial Carcinoma (EC)
  • Oklahoma City, Oklahoma
    Stephenson's Cancer Center
Nov 8, 2023

Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis Trial in Phoenix (Investigational Liver Fat Quantification

Completed
  • Non-Alcoholic Fatty Liver Disease
  • Non-Alcoholic Steatohepatitis
  • Investigational Liver Fat Quantification Software
  • Phoenix, Arizona
    Phoenix Children's Hospital
Jan 31, 2023

Thrombocytopenia, Immune, Heparin Induced Thrombocytopenia Trial (VLX-1005, Placebo)

Not yet recruiting
  • Thrombocytopenia, Immune
  • Heparin Induced Thrombocytopenia
  • (no location specified)
Mar 24, 2023

Social Anxiety in Autistic Adults Trial in Torrance (Placebo, 75 mg to 125 mg MDMA, Psychotherapy)

Completed
  • Social Anxiety in Autistic Adults
  • Placebo
  • +2 more
  • Torrance, California
    Los Angeles Biomedical Research Institute
Jun 14, 2022

Tauopathies Trial in Philadelphia (drug, diagnostic test, behavioral)

Active, not recruiting
  • Tauopathies
  • 11C-HY-2-15 PET
  • +3 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Sep 6, 2023

Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))

Not yet recruiting
  • Pancreatic Cancer Metastatic
  • C3 (Metformin, Simvastatin, and Digoxin)
  • (no location specified)
Sep 1, 2023

Decreased Immunologic Activity, Antibody-mediated Rejection Trial in Vienna (Combined apheresis)

Terminated
  • Decreased Immunologic Activity
  • Antibody-mediated Rejection
  • Combined apheresis
  • Vienna, Austria
    Division of Medicine III, Dpt. of Nephrology and Dialysis, Medic
Aug 22, 2022

Stroke, Acute, Stroke, Ischemic Trial in Beijing (LF-rTMS)

Not yet recruiting
  • Stroke, Acute
  • Stroke, Ischemic
  • LF-rTMS
  • Beijing, Beijing, China
    Beijing Tian tan Hospital
Sep 26, 2023

Stroke, Acute Ischemic Trial in Beijing (LF-rTMS, Sham stimulation)

Not yet recruiting
  • Stroke, Acute Ischemic
  • LF-rTMS
  • Sham stimulation
  • Beijing, Beijing, China
    Beijing Tian tan Hospital
Sep 26, 2023

Intracranial Hemorrhages Trial in Hamilton (Colchicine Pill, Placebo)

Recruiting
  • Intracranial Hemorrhages
  • Colchicine Pill
  • Placebo
  • Hamilton, Ontario, Canada
    Hamilton Health Sciences
Aug 12, 2022

Antibody-mediated Rejection Trial in Vienna, Berlin (Felzartamab, Placebo)

Recruiting
  • Antibody-mediated Rejection
  • Vienna, Austria
  • +1 more
Aug 23, 2022

Heart Failure Trial in Hamilton (Virtual HF Care, Routine HF Care)

Recruiting
  • Heart Failure
  • Virtual HF Care
  • Routine HF Care
  • Hamilton, Onatrio, Canada
  • +2 more
Feb 1, 2023

PTSD Trial in Boulder (Comparative-dose (40mg) MDMA, Active Dose 2 (100 mg) MDMA, Active Dose 1 (125 mg) MDMA)

Completed
  • Posttraumatic Stress Disorder
  • Comparative-dose (40mg) MDMA
  • +3 more
  • Boulder, Colorado
    Offices of Marcela d'Otalora
Jun 14, 2022

Lymphoid Leukemia, Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Tampa (CPX-351)

Active, not recruiting
  • Lymphoid Leukemia
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Dec 30, 2022

Breast Cancer, HER2-positive Trial in Houston (Zanidatamab, Letrozole, Tamoxifen)

Recruiting
  • Breast Cancer
  • HER2-positive
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

B-Cell Non-Hodgkin Lymphoma Trial in Seattle (Anakinra)

Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • Anakinra
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

PTSD Trial in Vancouver (Placebo, 3,4-methylenedioxymethamphetamine, Psychotherapy)

Terminated
  • Posttraumatic Stress Disorder
  • Placebo
  • +2 more
  • Vancouver, British Columbia, Canada
    Offices of Dr. Ingrid Pacey MBBS FRCP[C]
Jun 14, 2022

High-Risk de Novo Multiple Myeloma Trial in Spain (Daratumumab, Bortezomib, Lenalidomide)

Not yet recruiting
  • High-Risk de Novo Multiple Myeloma
  • Badalona, Spain
  • +9 more
Apr 27, 2023

Covid19, SARS-CoV Infection Trial in Rochester (Fisetin, Placebo)

Enrolling by invitation
  • Covid19
  • SARS-CoV Infection
  • Rochester, Minnesota
    Mayo Clinic
Jan 23, 2023

Intimate Partner Violence, Poverty Trial (Stepping Stones and Crating Futures Plus (SSCF+))

Not yet recruiting
  • Intimate Partner Violence
  • Poverty
  • Stepping Stones and Crating Futures Plus (SSCF+)
  • (no location specified)
Mar 24, 2023

Endometrial Cancers With FGFR2 Mutations Trial (FP-1039)

Withdrawn
  • Endometrial Cancers With FGFR2 Mutations
  • (no location specified)
Dec 9, 2021

Renal Transplant Rejection Trial in London (Fostamatinib)

Recruiting
  • Renal Transplant Rejection
  • London, United Kingdom
    Imperial College NHS Healthcare Trust
Oct 1, 2021

PTSD (PTSD) Trial in Be'er Ya'aqov (Active Placebo Dose MDMA (25 mg), Full Dose MDMA (125 mg), Open Label Full Dose MDMA (125

Completed
  • Posttraumatic Stress Disorder (PTSD)
  • Active Placebo Dose MDMA (25 mg)
  • +3 more
  • Be'er Ya'aqov, Israel
    Beer Yaakov Hospital
Jan 3, 2022

Tislelizumab Combing Chemoradiotherapy in Recurrent Cervical

Recruiting
  • Cervical Cancer
  • +2 more
  • Treatment Group
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
May 9, 2023

MDD Trial in New York (Empagliflozin)

Not yet recruiting
  • Major Depressive Disorder
  • New York, New York
    NYU Langone Health
Feb 24, 2023